EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 pce

7680670740166 CH-67074 C10BA02 07.12.0.

Reimbursement limitations:

EZETSIMVMeTe

Le remboursement s’applique lorsque les patients sont déjà traités par Ezetimib-Simvastatin-Mepha Teva.
Le remboursement …

EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 pce
EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 pce
EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 pce
1 / 3
google

Details

Product number
6707404
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
ezetimibum 10 mg, simvastatinum 80 mg, lactosum monohydricum 483.048 mg, hypromellosum, carmellosum natricum conexum, cellulosum microcristallinum, E 300, acidum citricum, E 320, E 310, magnesii stearas, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso corresp. natrium 4.3 mg.

Articles (1)

Ezetimib-Simvastatin-Mepha Teva 10/80 mg, Tabletten
Tabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/11/2024
Patient information leaflet
Français
29/11/2024
Patient information leaflet
Italien
29/11/2024
Professional SmPC
Allemand
29/11/2024
Professional SmPC
Français
29/11/2024
Professional SmPC
Italien
29/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
80.0 MG Substance Wirkstoff (Principe actif)
(N/A)
483.048 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
4.3 MG Substance HBESI

Reimbursement information

Public price
CHF 38.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2023

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
67074
Drug name
Ezetimib-Simvastatin-Mepha Teva, Tabletten
Galenic form
TAB
ATC Code
C10BA02
Authorization status
Z
Dispensation category
B
First authorization
22/06/2018
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 pce
Description (DE)
EZETIMIB SIMVASTATIN Mepha Teva 10/80 mg 28 Stk
Market launch
22/06/2018
Narcotic (BTM)
No

Original drug

Inegy, Tabletten
CHF 47.00
View original

Other packaging sizes

EZETIMIB SIMVASTATIN Mepha Teva 10/10 mg 28 pce
28 TABL
View
EZETIMIB SIMVASTATIN Mepha Teva 10/10 mg 98 pce
98 TABL
View
EZETIMIB SIMVASTATIN Mepha Teva 10/20 mg 28 pce
28 TABL
View
EZETIMIB SIMVASTATIN Mepha Teva 10/20 mg 98 pce
98 TABL
View